226 related articles for article (PubMed ID: 20173668)
41. Epigenetic regulation of androgen receptor gene expression in human prostate cancers.
Nakayama T; Watanabe M; Suzuki H; Toyota M; Sekita N; Hirokawa Y; Mizokami A; Ito H; Yatani R; Shiraishi T
Lab Invest; 2000 Dec; 80(12):1789-96. PubMed ID: 11140692
[TBL] [Abstract][Full Text] [Related]
42. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
43. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
Gozzini A; Santini V
Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
Keen JC; Garrett-Mayer E; Pettit C; Mack KM; Manning J; Herman JG; Davidson NE
Cancer Biol Ther; 2004 Dec; 3(12):1304-12. PubMed ID: 15662126
[TBL] [Abstract][Full Text] [Related]
45. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
46. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells].
Deng Y; Lu X; Liu L; Li T; Zhang Y; Guo X; Yu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):810-3. PubMed ID: 25108432
[TBL] [Abstract][Full Text] [Related]
47. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
[TBL] [Abstract][Full Text] [Related]
48. DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: evidence in human NT2 and NT2-N cells.
Zhang Z; Chen CQ; Manev H
J Neurochem; 2004 Mar; 88(6):1424-30. PubMed ID: 15009643
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.
Luo W; Karpf AR; Deeb KK; Muindi JR; Morrison CD; Johnson CS; Trump DL
Cancer Res; 2010 Jul; 70(14):5953-62. PubMed ID: 20587525
[TBL] [Abstract][Full Text] [Related]
51. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
52. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
[TBL] [Abstract][Full Text] [Related]
53. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells.
Ishimaru N; Fukuchi M; Hirai A; Chiba Y; Tamura T; Takahashi N; Tabuchi A; Tsuda M; Shiraishi M
Biochem Biophys Res Commun; 2010 Mar; 394(1):173-7. PubMed ID: 20188708
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
55. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
56. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
[TBL] [Abstract][Full Text] [Related]
58. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
59. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
60. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
